In details, it has been shown that Itch depletion by siRNA increases the cytotoxic effect of anti-neoplastic drugs in different cancer cell lines and the in vivo administration of siRNA duplex targeting Itch mRNA is effective in sensitizing pancreatic cancer to gemcitabine [29]. This evidence concerns the gene ITCH and pancreatic neoplasm.